Key points from article :
MIT has developed a tiny pump to be implanted into a patient’s brain.
Delivers precisely measured and targeted drugs to specific brain areas.
Could treat neurodegenerative disorders like Parkinson’s disease.
MiNDS can chemically modulate the local neuronal activity and related behavior.
Initial study performed lab rats and monkeys.
The study was published in the Science Translational Medicine journal.
